Skip to main content
. 2012 Feb 28;6:245. doi: 10.3332/ecancer.2012.245

Figure 1:

Figure 1:

Delayed reduction in the risk of colorectal cancer in the CAPP2 trial [8]. Reproduced with kind permission from The Lancet.